Glutamine transporters as regulators of prostate cancer radioresistance
MO-0140
Abstract
Glutamine transporters as regulators of prostate cancer radioresistance
1OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany, Institute of Radiooncology – OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Dresden, Germany, Dresden, Germany
Show Affiliations
Hide Affiliations
Purpose or Objective
We have previously shown that the radioresistant prostate cancer (PCa) and PCa stem
cells (CSCs) had increased glutamine (Gln) requirement (1). Gln conduces to
energy production in the TCA cycle to sustain the redox state and tumor
epigenetic resetting. Inhibition of the glutaminase-driven Gln catabolism set
the ground for CSC depletion and tumor radiosensitization (1). Moreover, we
demonstrated that autophagy is utilized by hormone-naive cells like LNCaP as a
prosurvival strategy to cope with the Gln depletion (1, 2). Despite our
previous study aiming to decipher mechanisms that link Gln metabolism and PCa
radioresistance, we sought to explain the role of Gln transporters (GTs) in PCa
development and radioresistance as it is not well understood and warrant
further investigation. Understanding the role of GTs may provide better
approaches for individualized treatment regimens to overcome PCa
radioresistance (3). Thus, we hypothesized that targeting GTs may yield novel and efficient strategies for PCa radiosensitization. As a result of in-silico analyses,
we focused on the solute carrier (SLC) group of membrane GTs, namely SLC1A5, SLC7A5,
and SLC38A1.
Material and Methods
Differential
expression of GTs in previously established parental and radioresistant DU145
and LNCaP PCa sublines is determined using global gene expression profiling and
qRT-PCR (4). Mining of publicly available patient datasets validated the
clinical relevance of the identified GT. To evaluate the role of GTs on PCa
radiosensitization, colony formation and sphere formation assays using PC3,
DU145, and LNCaP cells with siRNA-mediated knockdown of GTs has been performed.
Results
Depletion of our
candidates radiosensitizes PCa cell lines. Besides, reduced spherogenicity of
DU145 but not LNCaP cells was observed after GTs depletion. These results are
consistent with our published data showing that LNCaP cells use autophagy as a
prosurvival mechanism upon disruption of Gln metabolism, which may also explain
the unaltered spherogenicity of LNCaP cells upon depletion of GTs (1, 2).
Unlike DU145 cells, which do not express ATG5 and do not show
canonical autophagy, LNCaP cells are not solely dependent on the exogenous Gln
as they can use autophagy to survive (5). Additionally, we observed
statistically significant increased expression of GTs in DU145 cells compared
to LNCaP cells upon Gln starvation, which may recapitulate dependency of DU145
cells on Gln for survival.
Conclusion
Targeting SLC1A5, SLC7A5, and SLC38A1 might
offer a promising approach to radiosensitize PCa cells. Further studies to
evaluate these GTs in clinical specimens by IHC to validate them as prospective
biomarkers and in animal studies by their pharmacological inhibition may elucidate
their potential as a therapeutic target for PCa radiosensitization.
References
1- Mukha, A. &
Kahya, U. et al. Theranostics 2021
2- Mukha, A. et
al. Autophagy 2021
3- Kahya, U. et
al. Cancers 2021
4- Cojoc, M. et
al. Cancer Res 2015
5- Peitzsch, C. Int
J Radiat Biol 2014